L26/O-021 Advanced maternal age independently affects live birth and increases miscarriage risk in donor oocyte cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B. Crestani und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does uterine aging impact reproductive outcomes in donor oocyte cycles, and can it help identify a clinically relevant age threshold? Summary answer Recipient age ≥49 years independently predicts reduced live birth rates (LBR and cLBR), with an increased miscarriage risk, establishing a clinically relevant threshold in ART. What is known already Maternal age at childbirth has progressively increased due to sociocultural, economic, and technological factors. Although ovarian aging and oocyte competence have long been recognized as key determinants of fertility decline, emerging evidence indicates that uterine and endometrial aging also exert independent effects. Transcriptomic and molecular studies have revealed age-related impairments in endometrial receptivity, hormone responsiveness, and cellular homeostasis. However, clinical evidence quantifying the uterine contribution to reproductive outcomes remains limited. Donor oocyte cycles, which provide high-quality embryos, offer an ideal model to analyze the uterine factor, yet data defining a clinically meaningful threshold are still lacking. Study design, size, duration This retrospective cohort study included 1,774 patients who underwent 2,760 single blastocyst transfers (SETs) from oocyte donation between March 2021 and December 2024. SETs were stratified into four groups according to age: 35–40 years (n = 496), 41–45 years (n = 1,365), 46–49 years (n = 716), and ≥49 years (n = 183). Participants/materials, setting, methods Eligible women underwent single blastocyst transfer in natural or HRT cycles. Exclusion criteria included BMI > 30 kg/m², severe male factor infertility, endometrial thickness < 6.5 mm, and uterine malformations. Multivariate logistic regression was performed, adjusting for potential confounders such as embryo-, maternal-, and paternal-related factors. LBR, miscarriage rate, and endometrial pattern were assessed. Cumulative LBR was estimated through uncensored Kaplan–Meier analyses, which considered only completed embryo transfer cycles. Main results and the role of chance Donor oocyte age was stable across recipient age groups, while male partner age increased significantly from 39.1 ± 6.3 years in 35-40y to 47.4 ± 8.4 years in ≥ 49y (p < 0.0001). BMI (p < 0.001), PGT-A use (10.7% in 35–40y vs. 18.0% in ≥ 49y, p = 0.004), and HRT cycles (93.7% in 35-40y vs. 99.4% in ≥ 49y, p = 0.001) increased with age in recipients. The proportion of trilaminar endometrium declined from 94.7% (35–40y) to 81.0% (≥49y) (p < 0.0001), while endometrial thickness remained unchanged across age groups (p = 0.22). Clinical pregnancy rate declined significantly from 54.0% (35–40y) to 42.6% (≥49y) (p = 0.04), and live birth rate similarly decreased from 46.2% (35–40y) to 31.7% (≥49y) (p = 0.001). Miscarriage rate increased from 24.2% in the 35-40 y group to 37.6% in the ≥49y group (p = 0.0009). Compared to 35–40 years, women ≥49y had lower live birth OR 0.62 (95% CI 0.41–0.93, p = 0.02) and higher miscarriage risk OR 2.07 (95% CI 1.16–3.69, p = 0.01). The risk of non-trilaminar endometrium was higher in women ≥46y (46-49y OR 2.45, 95% CI 1.52–4.08, p = 0.0003; ≥49y OR 3.44, 95% CI 1.89–6.29, p < 0.0001). Kaplan–Meier analysis showed cLBRs declining from 80% (35–40y) to 62.5% 60% (≥49y) (p < 0.0001), among patients who transferred all available embryos. Limitations, reasons for caution The retrospective design may introduce residual confounding. Uterine pathologies, which increase with patient age, may be underreported in the database. Additionally, detailed data on vascular or metabolic factors potentially affecting implantation were not recorded. Further prospective studies are needed to validate these findings. Wider implications of the findings Despite donor oocytes, reproductive outcomes decline in recipients aged ≥49, suggesting a clinically significant effect of late uterine aging. As ART advances and societal trends increase pregnancies in this group, uterine factors may become the key limiting determinant, highlighting the need for age-specific assessment, counseling, and targeted interventions. Trial registration number No
Zitieren
APA
Crestani, B., Massaro, M., Parisi, A., Molinaro, P., Pellicer, A., & Cozzolino, M. (2026). L26/O-021 Advanced maternal age independently affects live birth and increases miscarriage risk in donor oocyte cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.021
Vancouver
Crestani B, Massaro M, Parisi A, Molinaro P, Pellicer A, Cozzolino M. L26/O-021 Advanced maternal age independently affects live birth and increases miscarriage risk in donor oocyte cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.021
BibTeX
@article{Crestani2026,
author = {Crestani, B. and Massaro, M.G. and Parisi, A. and Molinaro, P. and Pellicer, A. and Cozzolino, M.},
title = {L26/O-021 Advanced maternal age independently affects live birth and increases miscarriage risk in donor oocyte cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.021}
}
EUVIMED